Raymond James & Associates Mimedx Group, Inc. Transaction History

Raymond James & Associates

  • $146 Billion
  • Q1 2024

A detailed history of Raymond James & Associates transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 12,254 shares of MDXG stock, worth $83,572. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,254
Previous 12,970 5.52%
Holding current value
$83,572
Previous $113,000 16.81%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024
SELL
$7.61 - $8.63 $5,448 - $6,179
-716 Reduced 5.52%
12,254 $94,000
Q4 2023

Jan 16, 2024
BUY
$5.7 - $9.14 $73,929 - $118,545
12,970 New
12,970 $113,000
Q2 2023

Jul 25, 2023
SELL
$3.14 - $6.61 $12,874 - $27,101
-4,100 Reduced 7.4%
51,314 $339,000
Q4 2022

Feb 08, 2023
BUY
$2.63 - $3.45 $10,783 - $14,145
4,100 Added 7.99%
55,414 $154,000
Q3 2022

Oct 25, 2022
SELL
$2.71 - $4.22 $1,626 - $2,532
-600 Reduced 1.16%
51,314 $147,000
Q2 2022

Aug 12, 2022
BUY
$3.17 - $5.0 $133 - $210
42 Added 0.08%
51,914 $180,000
Q1 2022

May 11, 2022
SELL
$4.27 - $6.27 $22,784 - $33,456
-5,336 Reduced 9.33%
51,872 $244,000
Q4 2021

Feb 08, 2022
BUY
$5.7 - $8.48 $3,876 - $5,766
680 Added 1.2%
57,208 $346,000
Q3 2021

Nov 02, 2021
SELL
$5.52 - $15.83 $206,420 - $591,962
-37,395 Reduced 39.81%
56,528 $343,000
Q2 2021

Aug 11, 2021
SELL
$9.02 - $12.72 $481,758 - $679,375
-53,410 Reduced 36.25%
93,923 $1.18 Million
Q1 2021

May 14, 2021
BUY
$8.48 - $11.28 $626,697 - $833,625
73,903 Added 100.64%
147,333 $1.52 Million
Q4 2020

Feb 12, 2021
BUY
$5.32 - $10.17 $390,647 - $746,783
73,430 New
73,430 $667,000
Q4 2018

Feb 11, 2019
SELL
$1.15 - $6.45 $185,275 - $1.04 Million
-161,109 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$3.22 - $6.33 $14,168 - $27,852
-4,400 Reduced 2.66%
161,109 $996,000
Q2 2018

Aug 14, 2018
BUY
$5.39 - $8.96 $21,511 - $35,759
3,991 Added 2.47%
165,509 $1.06 Million
Q1 2018

May 14, 2018
SELL
$6.69 - $17.96 $115,629 - $310,420
-17,284 Reduced 9.67%
161,518 $1.13 Million
Q4 2017

Feb 14, 2018
SELL
$10.87 - $13.9 $369,210 - $472,127
-33,966 Reduced 15.96%
178,802 $2.26 Million
Q3 2017

Nov 13, 2017
BUY
$11.86 - $17.34 $425,299 - $621,812
35,860 Added 20.27%
212,768 $2.53 Million
Q2 2017

Aug 14, 2017
BUY
N/A
176,908
176,908 $2.65 Million

Others Institutions Holding MDXG

# of Institutions
218
Shares Held
94.7M
Call Options Held
221K
Put Options Held
77.4K
View Full List

About MIMEDX GROUP, INC.

MDXG Quotes by TradingView
  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $775M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email